Epigallocatechin-3-gallate reduces DNA damage induced by benzo[a]pyrene diol epoxide and cigarette smoke condensate in human mucosa tissue cultures

European Journal of Cancer Prevention

Volumn 18, Issue 3, 2009, Pages 230-235

  Baumeister, Philipp ^a   Reiter, Maximilian ^a   Kleinsasser, Norbert ^b   Matthias, Christoph ^c   Harréus, Ulrich ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Carcinogen; Cigarette smoke; DNA damage; Epigallocatechin gallate; Prevention

Indexed keywords

CATECHIN; CIGARETTE SMOKE; DIHYDROXYBENZO[A]PYRENE OXIDE; EPIGALLOCATECHIN GALLATE;

ADULT; ARTICLE; BIOPSY; CANCER PREVENTION; CLINICAL ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; INCUBATION TIME; MALE; OROPHARYNX; PRIORITY JOURNAL; UPPER GASTROINTESTINAL TRACT;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; ADOLESCENT; ADULT; ANTICARCINOGENIC AGENTS; ANTIMUTAGENIC AGENTS; CARCINOGENS; CATECHIN; CELLS, CULTURED; COMET ASSAY; DNA DAMAGE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOUTH MUCOSA; SMOKING; YOUNG ADULT;

EID: 68049129442     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32831bc3a0     Document Type: Article

References (34)

1. Baird WM, Hooven LA, Mahadevan B (2005). Carcinogenic polycyclic aromatic hydrocarbon-DNA adducts and mechanism of action. Environ Mol Mutagen 45:106-114.
2. Blot WJ, Chow WH, McLaughlin JK (1996). Tea and cancer: a review of the epidemiological evidence. Eur J Cancer Prev 5:425-438.
3. Boström CE, Gerde P, Hanberg A, Jernström B, Johansson C, Kyrklund T, et al. (2002). Cancer risk assessment, indicators, and guidelines for polycyclic aromatic hydrocarbons in the ambient air. Environ Health Perspect 110: 451-488.
4. Burlinson B, Tice RR, Speit G, Agurell E, Brendler-Schwaab SY, Collins AR, et al. (2007). Fourth International Workgroup on Genotoxicity testing: results of the in vivo comet assay workgroup. Mutat Res 627:31-35.
5. Chou FP, Chu YC, Hsu JD, Chiang HC, Wang CJ (2000). Specific induction of glutathione S-transferase GSTM2 subunit expression by epigallocatechin gallate in rat liver. Biochem Pharmacol 60:643-650.
6. Dakubo GD, Jakupciak JP, Birch-Machin MA, Parr RL (2007). Clinical implications and utility of field cancerization. Cancer Cell Int 7:11-22.
7. DeMarini DM (2004). Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 567:447-474.
8. Fairbairn DW, Walburger DK, Fairbairn JJ, O'Neill KL (1996). Key morphologic changes and DNA strand breaks in human lymphoid cells: discriminating apoptosis from necrosis. Scanning 18:407-416.
9. Frei B, Higdon JV (2003). Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275S-3284S.
10. Gray N, Kozlowski LT (2002). More on the regulation of tobacco smoke: how we got here and where next. Ann Oncol 14:353-357.
11. Halliwell B, Whiteman M (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231-255.
12. Henderson L, Wolfreys A, Fedyk J, Bourner C, Windebank S (1998). The ability of the comet assay to discriminate between genotoxins and cytotoxins. Mutagenesis 13:89-94.
13. IARC (1973). Certain polycyclic aromatic hydrocarbons and heterocyclic compounds. IARC Monogr Eval Carcinog Risk Chem Hum 3:91.
14. IARC (2002). Tobacco smoking and involuntary smoking. IARC Monogr. Eval Carcinog Risk Chem Hum 83:991-999.
15. Jernström B, Gräslund A (1994). Covalent binding of benzo[a]pyrene 7,8-dihydrodiol 9,10-epoxides to DNA: molecular structures, induced mutations and biological consequences. Biophys Chem 49:185-199.
16. Kanadzu M, Lu Y, Morimoto K (2006). Dual function of (-)-epigallocatechin gallate (EGCG) in healthy human lymphocytes. Cancer Lett 241:250-255.
17. Keshava C, Divi RL, Whipkey DL, Frye BL, McCanlies E, Kuo M, et al. (2005). Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a] pyrene. Cancer Lett 221:213-224.
18. Kleinsasser NH, Juchhoff J, Wallner BC, Bergner A, Harréus UA, Gamarra F, et al. (2004). The use of mini-organ cultures of human upper aerodigestive tract epithelia in ecogenotoxicology. Mutat Res 561:63-73.
19. Meintières S, Nesslany F, Pallardy M, Marzin D (2003). Detection of ghost cells in the standard alkaline comet assay is not a good measure of apoptosis. Environ Mol Mutagen 41:260-269.
20. Muto S, Fujita K, Yamazaki Y, Kamataki T (2001). Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 479:197-206.
21. Muto S, Yokoi T, Gondo Y, Katsuki M, Shioyama Y, Fujita K, Kamataki T (1999). Inhibition of benzo[a]pyrene-induced mutagenesis by (-)-epigallocatechin gallate in the lung of rpsL transgenic mice. Carcinogenesis 20:421-424.
22. Nagle DG, Ferreira D, Zhou YD (2006). Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 26:769-775.
23. Netsch MI, Gutmann H, Schmidlin CB, Aydogan C, Drewe J (2006). Induction of CYP1A by green tea extract in human intestinal cell lines. Planta Med 72:514-520.
24. Olive PL, Banáth JP (2006). The comet assay: a method to measure DNA damage in individual cells. Nat Protoc 1:23-29.
25. Phillips DH (1999). Polycyclic aromatic hydrocarbons in the diet. Mutat Res 443:139-147.
26. Sarkadi B, Homolya L, Szakacs G, Varadi A (2006). Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev 86:1179-1236.
27. Schmeichel KL, Bissell MJ (2003). Modeling tissue-specific signalling and organ function in three dimensions. J Cell Sci 116:2377-2388.
28. Sporn MB (1976). Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res 36:2699-2702.
29. Srivastava SK, Xia H, Pal A, Hu X, Guo J, Singh SV (2000). Potentiation of benzo[a]pyrene-induced pulmonary and forestomach tumorigenesis in mice by D,L-buthionine-S,R-sulfoximine-mediated tissue glutathione depletion. Cancer Lett 153:35-39.
30. Teissier E, Fennrich S, Strazielle N, Daval JL, Ray D, Schlosshauer B, Ghersi-Egea JF (1998). Drug metabolism in in vitro organotypic and cellular models of mammalian central nervous system: activities of membrane-bound epoxide hydrolase and NADPH-cytochrome P-450 (c) reductase. Neurotoxicology 19:347-355.
31. Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS, et al. (2003). A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 31:88-101.
32. Vasiluk L, Pinto LJ, Tsang WS, Gobas FA, Eickhoff C, Moore MM (2008). The uptake and metabolism of benzo[a]pyrene from a sample food substrate in an in vitro model of digestion. Food Chem Toxicol 46:610-618.
33. Yeh GC, Lopaczynska J, Poore CM, Phang JM (1992). A new functional role for P-glycoprotein: efflux pump for benzo(alpha)pyrene in human breast cancer MCF-7 cells. Cancer Res 52:6692-6695.
34. Yen GC, Chen HY (1998). Scavenging effect of varioustea extracts on superoxide derived from the metabolism ofmutagens. Biosci Biotechnol Biochem 62:1768-1770.